| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6114292 | Transfusion and Apheresis Science | 2013 | 9 Pages |
Abstract
Methylene blue treated plasma showed reduced coagulation factor (CF) activity and protein levels. The MB treatment-induced damage to the proteins was acceptable at the four Chinese blood centers, but the quality of the MB-treated plasma in general was not satisfactory. The main factor affecting plasma quality may be the duration of the collection and processing.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Yang Chunhui, Bian Guohui, Yang Hong, Xiao Xiaopu, Bai Zherong, Wang Mingyuan, Zhang Xinsheng, Wang Juanjuan, Li Changqing, Li Wuping,